1Departments of Medicine and Community Health Sciences, University of Calgary, and Alberta Health Services, AGW5 Ground Floor SSB, 1403 29 St NW, Calgary, AB T2N 2T9 Canada.
2Departments of Medicine, Immunology, Microbiology and Infectious Diseases, Pathology and Laboratory Medicine, O'Brien Institute for Public Health and Snyder Institute for Chronic Diseases, University of Calgary and Alberta Health Services, Calgary, AB Canada.
Antimicrob Resist Infect Control. 2018 Feb 27;7:31. doi: 10.1186/s13756-018-0327-z. eCollection 2018.
The objective of this review is to provide a comprehensive overview of the different types of economic evaluations that can be utilized by Infection Prevention and Control practitioners with a particular focus on the use of the quality adjusted life year, and its associated challenges. We also highlight existing economic evaluations published within Infection Prevention and Control, research gaps and future directions.
Narrative Review.
To date the majority of economic evaluations within Infection Prevention and Control are considered partial economic evaluations. Acknowledging the challenges, which include variable utilities within infection prevention and control, a lack of randomized controlled trials, and difficulty in modelling infectious diseases in general, future economic evaluation studies should strive to be consistent with published guidelines for economic evaluations. This includes the use of quality adjusted life years. Further research is required to estimate utility scores of relevance within Infection Prevention and Control.
本综述的目的是提供感染预防和控制从业者可使用的不同类型经济评估的全面概述,特别关注质量调整生命年的使用及其相关挑战。我们还强调了感染预防和控制领域内已发表的现有经济评估、研究差距和未来方向。
叙述性综述。
迄今为止,感染预防和控制领域内的大多数经济评估被认为是部分经济评估。鉴于存在的挑战,包括感染预防和控制中效用的可变性、缺乏随机对照试验以及一般传染病建模的困难,未来的经济评估研究应努力符合经济评估的已发表指南。这包括使用质量调整生命年。需要进一步研究以估算感染预防和控制中相关的效用得分。